AHB-137

· Ausper Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AHB-137, covering 2025-02-14 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region [Phase 2]

See pricing